ICU Medical (NASDAQ: ICUI) and DENTSPLY SIRONA (NASDAQ:XRAY) are both mid-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk and valuation.

Profitability

This table compares ICU Medical and DENTSPLY SIRONA’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
ICU Medical 6.10% 7.56% 6.20%
DENTSPLY SIRONA -20.57% 7.24% 5.02%

Dividends

DENTSPLY SIRONA pays an annual dividend of $0.35 per share and has a dividend yield of 0.6%. ICU Medical does not pay a dividend. DENTSPLY SIRONA pays out -10.1% of its earnings in the form of a dividend.

Risk and Volatility

ICU Medical has a beta of 0.36, indicating that its share price is 64% less volatile than the S&P 500. Comparatively, DENTSPLY SIRONA has a beta of 1.28, indicating that its share price is 28% more volatile than the S&P 500.

Institutional and Insider Ownership

78.1% of ICU Medical shares are held by institutional investors. Comparatively, 94.0% of DENTSPLY SIRONA shares are held by institutional investors. 15.9% of ICU Medical shares are held by company insiders. Comparatively, 2.0% of DENTSPLY SIRONA shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Earnings & Valuation

This table compares ICU Medical and DENTSPLY SIRONA’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
ICU Medical $772.05 million 4.52 $92.48 million $2.62 67.14
DENTSPLY SIRONA $3.84 billion 3.38 $825.00 million ($3.47) -16.28

DENTSPLY SIRONA has higher revenue and earnings than ICU Medical. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent recommendations for ICU Medical and DENTSPLY SIRONA, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ICU Medical 0 2 1 0 2.33
DENTSPLY SIRONA 1 2 8 0 2.64

DENTSPLY SIRONA has a consensus price target of $66.20, indicating a potential upside of 17.19%. Given DENTSPLY SIRONA’s stronger consensus rating and higher possible upside, analysts clearly believe DENTSPLY SIRONA is more favorable than ICU Medical.

Summary

DENTSPLY SIRONA beats ICU Medical on 9 of the 16 factors compared between the two stocks.

About ICU Medical

ICU Medical, Inc. is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems. The primary critical care products it manufactures are Hemodynamic Monitoring Systems, SafeSet Closed Blood Sampling and Conservation System, Transpac Consumable Blood Pressure Transducers and Other Critical Care Products. The primary oncology products it manufactures are ChemoLock Needlefree CSTD, ChemoClave Needlefree CSTD and Diana Hazardous Drug Compounding System. As of December 31, 2016, its products were used in acute care hospitals and ambulatory clinics in more than 65 countries throughout the world.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies. The dental industry encompasses the diagnosis, treatment and prevention of disease and ailments of the teeth, gums and supporting bone. Its principal dental product categories are dental consumable products, dental laboratory products, dental specialty products and dental equipment. Additionally, its consumable medical device products are used for urological and surgical applications. These products are produced by the Company in the United States and internationally and are distributed throughout the world under various brand names, including ANKYLOS, AQUASIL ULTRA, ARTICADENT, ATLANTIS, CALIBRA, CAULK, CAVITRON, CELTRA, DELTON, DENTSPLY, DETREY and DYRACT.

Receive News & Stock Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related stocks with our FREE daily email newsletter.